Vulnerability · CVE-2026-27009
OpenClaw is a personal AI assistant.
Published Feb 20, 2026 · catalog updated Jun 17, 2026 · OpenClaw is a personal
Check if you run it
No confirmed exploitation is on record for CVE-2026-27009. EPSS is 0.26%. Act only if a listed version of OpenClaw is a personal is installed.
Gaps on this record
- The stored product name is a package slug. The name on this page is taken from the title (OpenClaw is a personal).
- No version range is stored. A customer cannot check an installed version against this record.
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Medium5.8
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.26%
- Remediation
- Advisory link
- Affected products
- cpe openclaw/openclaw
OpenClaw is a personal AI assistant. Prior to version 2026.2.15, a atored XSS issue in the OpenClaw Control UI when rendering assistant identity (name/avatar) into an inline tag without script-context-safe escaping. A crafted value containing could break out of the script tag and execute attacker-controlled JavaScript in the Control UI origin. Version 2026.2.15 removed inline script injection and serve bootstrap config from a JSON endpoint and added a restrictive Content Security Policy for the Control UI ( , no inline scripts).
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- cpe openclaw/openclawversion unspecified
How to fix CVE-2026-27009
Recommended remediation
A patch or advisory reference is linked. Open the original publisher for availability by product version.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2026-27009. EPSS is 0.26%. Act only if a listed version of OpenClaw is a personal is installed.
Which versions are affected?
Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-79: Cross-site Scripting (XSS). EPSS 0.26%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
Timeline
Detection, updates, and resolution for this record.
Feb 20, 2026 · NIST NVD
Detected
OpenClaw is a personal AI assistant. Prior to version 2026.2.15, a atored XSS issue in the OpenClaw Control UI when rendering assistant identity (name/avatar) into an inline tag without script-context-safe escaping. A crafted value containing could break out of the script tag and execute attacker-controlled JavaScript in the Control UI origin. Version 2026.2.15 removed inline script injection and
Jun 17, 2026 · NIST NVD
Updated
OpenClaw is a personal AI assistant. Prior to version 2026.2.15, a atored XSS issue in the OpenClaw Control UI when rendering assistant identity (name/avatar) into an inline tag without script-context-safe escaping. A crafted value containing could break out of the script tag and execute attacker-controlled JavaScript in the Control UI origin. Version 2026.2.15 removed inline script injection and
Sources
- CVE.orgVulnerability recordCVE-2026-27009
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2026-27009
30-day exploitation probability 0.3%
first.org - NIST NVDVulnerability recordCVE-2026-27009
OpenClaw is a personal AI assistant. Prior to version 2026.2.15, a atored XSS issue in the OpenClaw Control UI when rendering assistant identity (name/avatar) into an inline tag without script-context-safe escaping. A crafted value containing could break ou
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.